2022-10-28 2023-10-27 false Capium Accounts Production 1.1 07051383 bus:AbridgedAccounts 2022-10-28 2023-10-27 07051383 bus:FRS102 2022-10-28 2023-10-27 07051383 bus:AuditExemptWithAccountantsReport 2022-10-28 2023-10-27 07051383 bus:SmallCompaniesRegimeForAccounts 2022-10-28 2023-10-27 07051383 bus:PrivateLimitedCompanyLtd 2022-10-28 2023-10-27 07051383 2022-10-28 2023-10-27 07051383 2023-10-27 07051383 bus:RegisteredOffice 2022-10-28 2023-10-27 07051383 core:WithinOneYear 2023-10-27 07051383 core:AfterOneYear 2023-10-27 07051383 bus:Director1 2022-10-28 2023-10-27 07051383 bus:Director1 2023-10-27 07051383 bus:Director1 2021-10-28 2022-10-27 07051383 2021-10-28 07051383 bus:LeadAgentIfApplicable 2022-10-28 2023-10-27 07051383 2021-10-28 2022-10-27 07051383 2022-10-27 07051383 core:WithinOneYear 2022-10-27 07051383 core:AfterOneYear 2022-10-27 07051383 bus:EntityAccountantsOrAuditors 2021-10-28 2022-10-27 07051383 bus:OrdinaryShareClass1 2022-10-28 2023-10-27 07051383 bus:OrdinaryShareClass1 2023-10-27 07051383 bus:OrdinaryShareClass1 2021-10-28 2022-10-27 07051383 bus:OrdinaryShareClass1 2022-10-27 07051383 core:PlantMachinery 2022-10-28 2023-10-27 07051383 core:PlantMachinery 2023-10-27 07051383 core:PlantMachinery 2022-10-27 07051383 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-10-27 07051383 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-10-27 07051383 core:CostValuation core:Non-currentFinancialInstruments 2023-10-27 07051383 core:CostValuation core:Non-currentFinancialInstruments 2022-10-27 07051383 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-10-27 07051383 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-10-27 07051383 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-10-27 07051383 core:Non-currentFinancialInstruments 2023-10-27 07051383 core:Non-currentFinancialInstruments 2022-10-27 07051383 core:ShareCapital 2023-10-27 07051383 core:ShareCapital 2022-10-27 07051383 core:RetainedEarningsAccumulatedLosses 2023-10-27 07051383 core:RetainedEarningsAccumulatedLosses 2022-10-27 07051383 dpl:Item1 2022-10-28 07051383 dpl:Item1 2023-10-27 07051383 dpl:Item1 2021-10-28 07051383 dpl:Item1 2022-10-27 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07051383


 

 

 

LAKESIDE MEDICAL DIAGNOSTICS LIMITED


Abridged Accounts
 


Period of accounts

Start date: 28 October 2022

End date: 27 October 2023
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Tangible fixed assets 3 68,055    73,425 
68,055    73,425 
Current assets      
Debtors 308,299    301,946 
Creditors: amount falling due within one year (98,153)   (79,797)
Net current assets 210,146    222,149 
 
Total assets less current liabilities 278,201    295,574 
Creditors: amount falling due after more than one year (25,829)   (35,840)
Net assets 252,372    259,734 
 

Capital and reserves
     
Called up share capital 4 1    1 
Profit and loss account 252,371    259,733 
Shareholders' funds 252,372    259,734 
 


For the year ended 27 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 29 July 2024 and were signed by:


-------------------------------
Dr Tham Nimal-Raj
Director
1
General Information
LAKESIDE MEDICAL DIAGNOSTICS LIMITED is a private company, limited by shares, registered in , registration number 07051383, registration address East Tilbury Medical Centre, 85, Coronation Avenue, East Tilbury, RM18 8SW.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of trade discounts where applicable.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
25% on reducing balance

Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 15 (2022 : 12).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Total
  £   £
At 28 October 2022 132,136    132,136 
Additions 14,879    14,879 
Disposals  
At 27 October 2023 147,015    147,015 
Depreciation
At 28 October 2022 58,711    58,711 
Charge for year 20,249    20,249 
On disposals  
At 27 October 2023 78,960    78,960 
Net book values
Closing balance as at 27 October 2023 68,055    68,055 
Opening balance as at 28 October 2022 73,425    73,425 


4.

Share Capital

Allotted, called up and fully paid
2023
£
  2022
£
1 Class A share of £1.00 each  
 

2